Coverage
-
March 14, 2023
Two biopharmaceutical executives must resolve some of their sex bias and retaliation claims against their ex-employer outside of court, despite a new federal law blocking the arbitration of sexual misconduct claims, a Utah federal judge said, because the disputes arose before the law was enacted.
2 other articles on this case.
View all »